Dr. Donald B. Calne
Affiliations
- In 1981 Dr. Calne was appointed Director of the Neurodegenerative Disorders Centre at the University of British Columbia (Canada).
- Professor emeritus, UBC
- Chairman of the World Federation of Neurology Research Group on Parkinsonism and Related Disorders.
- Officer of the Order of Canada,
- Fellow of the Royal Society of Canada,
- D.Sc. honoris causa, from the University of British Columbia .
Training
-
Bachelor of Arts, Bachelor of Science and Doctor of Medicine degrees from Oxford.
- Neurologist at the Royal Postgraduate Medical School in London (UK),
- Clinical Director and Chief of the Experimental Therapeutics Branch of the National Institute of Neurological Diseases and Stroke, Bethesda (USA).
Research Interests
- Etiopathogenesis of Parkinson ’ s disease, and the exploration of new approaches to antiparkinson therapy.
- Introduced the first synthetic dopamine agonist for the treatment for Parkinson’ s disease.
- With Dr Kebabian, he defined two types of synaptic receptor for dopamine.
Recent Representative Publications
Dr Calne has published over 500 papers and chapters on neurological subjects; he has written four books (one as a joint author) and he has edited nine books.
Contact Information
Room M36, UBC Hospital, Purdy Pavilion
2221 Wesbrook Mall,
Vancouver BC, V6T 2B5. Fax 604 822 7866